- Asian shares trade mixed amid the US dollar’s sustained run-up and return of Tokyo’s traders.
- BOJ’s Kuroda favors stabilization in markets, RBNZ stood pat on rates, LSAP.
- Aussie Retail Sales slumped but the passage of US stopgap funding countered the bears.
- September month PMIs are in focus amid serious concerns over virus wave 2.0.
Asian equities fail to track Wall Street gains as the US dollar’s run-up battles the coronavirus (COVID-19) concerns. As a result, the MSCI index of Asia-Pacific shares outside Japan fails to move much, down 0.05% now, while Japan’s Nikkei 225 flashes 0.40% losses during the pre-European open on Wednesday.
The US Congress passes the bill to avoid the October month shutdown but the latest COVID-19 cluster in Brooklyn fails to recall the bulls. Even so, stocks in Australia and New Zealand manage to rise notably amid separate catalysts. While Australia’s ASX 200 cheers upbeat prints of the Commonwealth Bank of Australia’s (CBA) PMIs, up over 2.0%, New Zealand’s NZX 50 takes clues from the Reserve Bank of New Zealand’s (RBNZ) inaction and registers 1.25% upside as we write.
Elsewhere, stocks in China fail to entertain traders with mild losses but Japanese traders react to the latest risk-off mood as they return from a four-day holiday. Furthermore, South Korea’s KOSPI and Indonesia’s IDX Composite follow the footsteps of Beijing’s shares. However, India’s BSE Sensex adds minor gains amid recently receding virus figures.
On Tuesday, Wall Street closed on the positive side technology shares propelled the run-up. Also helping the bulls were upbeat US data and nothing new from the Federal Reserve Chairman Jerome Powell during testimony.
That said, S&P 500 Futures stay mostly unchanged around 3,300 while the US 10-year Treasury yields stay mildly positive near 0.67% by the time of the press.
Looking forward, the initial estimation of September month Manufacturing and Services activities from Europe, the UK and the US will be the key to watch. Although no major good news is likely to arrive from scheduled PMIs, sustained recovery from the previous numbers, which is less likely, can keep the latest risk-on mood.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD extends gains above 1.0700, focus on key US data
EUR/USD meets fresh demand and rises toward 1.0750 in the European session on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data.
USD/JPY keeps pushing higher, eyes 156.00 ahead of US GDP data
USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, recapturing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming intervention risks. The focus shifts to Thursday's US GDP report and the BoJ decision on Friday.
Gold closes below key $2,318 support, US GDP holds the key
Gold price is breathing a sigh of relief early Thursday after testing offers near $2,315 once again. Broad risk-aversion seems to be helping Gold find a floor, as traders refrain from placing any fresh directional bets on the bright metal ahead of the preliminary reading of the US first-quarter GDP due later on Thursday.
Injective price weakness persists despite over 5.9 million INJ tokens burned
Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price.
US Q1 GDP Preview: Economic growth set to remain firm in, albeit easing from Q4
The United States Gross Domestic Product (GDP) is seen expanding at an annualized rate of 2.5% in Q1. The current resilience of the US economy bolsters the case for a soft landing.